ENTITY
UCB SA

UCB SA (UCB BB)

20
Analysis
Health CareBelgium
UCB SA is a biopharmaceutical company. The Company specializes in the treatment of central nervous system disorders and inflammatory diseases. UCB operates worldwide.
more
Refresh
bullishNippon Shinyaku
30 Nov 2022 21:59

Nippon Shinyaku (4516 JP): Viltepso Has Strong Muscle Power; New Seizure Drug Launch in Japan

Strong performance of DMD drug Viltepso in US market and reviving functional food business have enabled the company to raise FY23 guidance. Late...

Logo
404 Views
Share
bullishEli Lilly & Co
07 Apr 2022 01:19

Buy Global LargeCap Pharma: LLY, AZN, NOVO.B-DK, ROG-CH, BMY, BAYN-DE, UCB-BE, IPN-FR, 4528-JP, TEVA

The VanEck Pharmaceutical ETF $PPH recently broke out topside a 9-month base and RS displays a bullish reversal. Zooming-out, we can see a 6+ year...

Logo
272 Views
Share
24 Sep 2021 21:49

Global Energy Sector Improving -- Buying Reliance Industries Ltd, Several Others

Crude oil prices display bullish short-term reversals, resulting in bullish price and RS reversals for global Energy stocks -- add exposure.

Logo
420 Views
Share
19 May 2020 22:44

SK Biopharm IPO Preview

SK Biopharmaceuticals (BIO SK) is getting ready to complete an IPO in the Korean stock market in June. The SK Biopharm will be one of the biggest...

Logo
235 Views
Share
22 Oct 2018 22:52

Samsung BioLogics Update

Recent developments in Samsung Biologics Co., (207940 KS)'s business have been mixed with a negative skew. First, partner Merck & Co Inc (MRK...

Share
x